Article
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases.
Cephalalgia : an international journal of headache - 1 Jun 2023
Buture Alina, Tomkins Esther M, Shukralla Arif, Troy Emma, Conaty Katie, Macken Esther, Lonergan Roisin, Melling Jane, Long Niamh, Birrane Kieran, Shaikh Eamonn, Goadsby Peter J, Ruttledge Martin H
Abstract excerpt
BACKGROUND: Patients diagnosed with New Daily Persistent Headache and Persistent Post-Traumatic Headache belong to a heterogeneous group of primary and secondary headache disorders, with the common clinical feature that these conditions start abruptly, continue unabated, and are refractory to conventional migraine preventive treatments. OBJECTIVE: This is a real-world, medium-term audit to explore whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.